Connect with us:
  • |#lymsm
I'm interested in

  • All subtypes
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia
  • Diffuse Large B-Cell Lymphoma
  • Follicular Lymphoma
  • Hodgkin Lymphoma
  • Mantle Cell Lymphoma
  • Marginal Zone Lymphoma
  • Rare Lymphoma

    Rare Lymphoma

    Rare Lymphoma
    • Burkitt Lymphoma
    • High-grade B-cell lymphoma, NOS
    • Primary CNS lymphoma
    • Waldenström Macroglobulinemia
    • Hairy Cell Leukemia
  • T-Cell Lymphoma

    T-Cell Lymphoma

    T-Cell Lymphoma
    • EBV+ T-cell lymphomas
    • Enteropathy-associated T-cell lymphoma
    • Follicular T-cell related lymphoma
    • Indolent T-cell lymphoproliferative disorders (LPD) of the GI tract
    • Lymphoma, T-Cell, Cutaneous
    • PTCL
    • Precursor T-lymphoblastic lymphoma/leukemia

Interested in specific subtype?

Filter what you see here

  • Medical Information
  • Licenses
  • Trials
  • About
  • Sign Up
237 articles |Clear filters Filter
Keyword search

Topic

Categories

Congress Coverage

Clear filters

237 articles|Clear filters

MCL

EHA-SWG 2017 | Rare Lymphomas: current and future treatment of MCL

On March 10–12 2017, the EHA-SWG meeting on Rare Lymphomas took place in Barcelona, Spain, and was jointly chaired by Prof. Martin Dreyling,…

Terri Penfold , Mar 15, 2017

MCL

EHA-SWG 2017 | Rare Lymphomas: advances in biology of MCL

On March 10–12 2017, the EHA-SWG meeting on Rare Lymphomas took place in Barcelona, Spain, and was jointly chaired by Prof. Martin Dreyling,…

Terri Penfold , Mar 15, 2017

PTCL,   CTCL

EHA-SWG 2017 | Rare Lymphomas: T-Cell Lymphoma novel treatment options

On March 10–12 2017, the EHA-SWG meeting on Rare Lymphomas took place in Barcelona, Spain, and was jointly chaired by Prof. Martin Dreyling,…

Terri Penfold Charlotte Chapman , Mar 14, 2017

PTCL

EHA-SWG 2017 | Rare Lymphomas: Biology of T-Cell Lymphomas

On March 10–12 2017, the EHA-SWG meeting on Rare Lymphomas took place in Barcelona, Spain, and was jointly chaired by Prof. Martin Dreyling,…

Terri Penfold , Mar 13, 2017

CLL/SLL

ESMO 2016 | Educational Session: CLL – Moving towards chemotherapy free approaches

At this year’s ESMO conference, during an educational session, Professor Paolo Ghia of the Vita-Salute San Raffaele University in Milan gave a…

Terri Penfold , Nov 16, 2016

MCL

ESMO 2016 | Educational Session – MCL: Current and novel therapy

Professor of Clinical Hematology, Simon Rule from the Derriford Hospital and Peninsula Medical School, Plymouth, UK, presented a session focused on…

Terri Penfold , Nov 16, 2016

EATL

ESMO 2016 | Educational Session – EATCL: Enteropathy associated T-cell lymphomas

Dr Otto Visser from the Department of Hematology, VU University Medical Center, Amsterdam, presented a lecture during an educational session at this…

Terri Penfold , Nov 16, 2016

MZL

ESMO 2016 | Educational Session – MZL: Recent Developments in Diagnostics and Therapeutics

Professor Catherine Thieblemont from the Hôpital Saint-Louis in Paris, France, presented an educational session on the latest developments in…

Karl Kemp-O'Brien , Nov 16, 2016

FL

ESMO 2016 | Educational Session – FL: novel developments beyond chemotherapy

The ESMO 2016 congress took place in Copenhagen, Denmark, on 7–11 October, and is considered the most important European meeting to present…

Terri Penfold , Nov 16, 2016

HGBL

ESMO 2016 | Multidisciplinary Cases Session: Therapy regimens for treatment of patients with Central Nervous System (CNS)…

Andrés J.M. Ferreri from the IRCCS San Raffaele Scientific Institute presented a multidisciplinary session focused on studies on patients with…

Cynthia Umukoro , Nov 16, 2016

  • 1
  • ...
  • 21
  • 22
  • 23
  • 24

Professional society

The European Lymphoma Institute is comprised of a network of top European specialists in the field of lymphoma who are dedicated to research, training and education. Together they look to define strategies to analyse and characterize lymphoma and its common diagnostic procedures and therapeutic standards, as well as to facilitate clinical and fundamental research. This all results in the advancement of lymphoma research and it guarantees equal access for all patients to the best possible care.


Our partners


Our supporters

Platinum
Silver
Silver
Silver
Bronze
Bronze
Contributor
  • Terms and conditions
  • Cookie policy
  • Privacy policy
  • Newsletter

© 2019 Lymphoma Hub

All content on this site is intended for healthcare professionals only.
If you are a patient or carer, please visit the Lymphoma Coalition.